Locoregional delivery of CAR-T cells in the clinic
Authors:
- 27 June 2022
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 182, 106329
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)BMC Cancer, 2012
- Palliation and Pleurodesis in Malignant Pleural Effusion: The Role for Tunneled Pleural CathetersJournal of Thoracic Oncology, 2011
- Review: Practical considerations in ovarian cancer chemotherapyTherapeutic Advances in Medical Oncology, 2010
- Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal CarcinomaJournal of Clinical Oncology, 2009
- Noninvasive detection of therapeutic cytolytic T cells with 18F–FHBG PET in a patient with gliomaNature Clinical Practice Oncology, 2008
- Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesisEuropean Respiratory Journal, 2007
- Intraperitoneal Chemotherapy of Ovarian Cancer: A Review, With a Focus on Practical Aspects of TreatmentJournal of Clinical Oncology, 2006
- Intraperitoneal Cisplatin and Paclitaxel in Ovarian CancerNew England Journal of Medicine, 2006
- Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group StudyGynecologic Oncology, 2006
- Assessment of complications of EUS-guided fine-needle aspirationGastrointestinal Endoscopy, 2001